Added to YB: 2026-04-22
Pitch date: 2026-04-20
CDIO [neutral]
Cardio Diagnostics Holdings, Inc.
-2.59%
current return
Author Info
Stock Pursuit researches domestic deep value equities below net cash, net current asset value or net tangible assets. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Market Cap
$5.9M
Pitch Price
$1.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.26
P/E
-0.54
EV/Sales
103.44
Sector
Biotechnology
Category
growth
Show full summary:
Deep Value Roundup Part II - Cardio Diagnostics Holdings, Inc.
CDIO (update): Secured first India contract with Dr. Lal Pathlabs (290+ labs, 300+ pathologists) early 2025. Tests ready for commercialization. Huge addressable market but limited new info since March update.
Read full article (1 min)